A

Linking Cardiovascular Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): The Role of Cardiometabolic Drugs in MASLD Treatment

Biomolecules

Authors 0

  1. Author list not loaded yet.

Cited by 1 stored of 38

1 result

References 1

1 result